Tracking glucose tolerance in patients with type 2 diabetes using technology
Official title: A Participatory Approach to Support Glucose Tolerance Tracking in Real-Life of Patients With Type 2 Diabetes
Run by University of Pavia · NCT06864546 · Data updated 2026-11-12
This study is testing if using continuous glucose monitors and health tracking devices can help people with type 2 diabetes who aren't on insulin make better lifestyle choices to manage their blood sugar levels.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 70 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Pavia Academic / other |
| Locations | 1 site (Pavia, Pavia) |
| Status | Recruiting |
| Started | May 2025 |
| Main results expected | December 2025 |
| Study ends | January 15, 2026 |
| Registry record updated | April 30, 2025 |
| Trial ID | NCT06864546 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are sedentary individuals aged 40 to 70 with non-insulin treated type 2 diabetes.
✕Probably not a fit
Patients who have been diagnosed with diabetes for less than three years or those with significant heart disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance the management of type 2 diabetes through a participatory e-health approach that utilizes continuous glucose monitors (CGM) and other health tracking devices. By collecting real-time health data from patients, the study will develop an easy-to-use tool for tracking metabolic status and analyze the relationship between lifestyle changes and glucose levels. The focus is on sedentary individuals with type 2 diabetes who are not on insulin treatment, promoting lifestyle interventions to improve their health outcomes.
Why it matters
Potential benefit: If successful, this approach could empower patients to better manage their diabetes and potentially reverse their condition through lifestyle changes.
How similar studies have gone: While many studies have shown success with CGM devices in type 1 diabetes and advanced type 2 diabetes, this approach in non-insulin treated type 2 diabetes is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Non-insulin treated T2D diagnosis (not treated at all or only with metformin); * Physically inactive (less than 150 minutes/week of moderate physical activity); * Age between 40 and 70; * HbA1c below 8.5%. Exclusion Criteria: * Diabetes diagnosis less than 3 years before the study initiation; * Pregnancy; * Symptomatic heart disease, e.g. history of myocardial infarction, coronary bypass, stenting procedure, angina, or any ischemic cerebrovascular event; * Use of a medication that significantly impacts glucose metabolism (oral steroids); * Use of a medication that significantly lowers heart rate (beta blockers, reserpine, guanethidine, methyldopa, clonidine, cimetidine, digitalis, calcium channel blockers, amiodarone, antiarrhythmic drugs, or lithium); * Atrial fibrillation; * Use of an electronic pacemaker.
Where it's running
-
Istituti Clinici Scientifici Maugeri di Pavia
Pavia, Pavia, Italy Recruiting
Study contacts
- Study coordinator: Enea Parimbelli
- Email: enea.parimbelli@unipv.it
- Phone: +39 0382 9895981
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Neurophysiological and Autonomic Responses to Acute Stress
This study tests how the brain and body respond to four short stress tasks in healthy adults.
-
Does AI-based cephalometric tracing match digital manual tracing for orthodontic measurements?
This study tests whether AI-powered cephalometric analysis can produce measurements similar to traditional digital tracing in 100 patient radiographs.
-
Amino acids plus diet and exercise for people with FSHD
This trial will test whether taking essential amino acid supplements together with a structured diet and exercise program helps adults with FSHD build muscle, reduce fat, and improve physical performance compared with placebo and matched healthy adults.
-
Ozone gas plus biomimetic toothpaste and mouthwash to treat cancer therapy mouth sores
This trial will test whether adding a biomimetic toothpaste and mouthwash to ozone gas therapy helps adults with chemo- or radiotherapy-induced mouth sores heal faster and have less pain.
-
Trehalose versus glycine air-polishing for peri-implant mucositis
This trial will see if trehalose or glycine powder used with air-polishing better reduces plaque and bleeding around dental implants in adults with peri-implant mucositis.
-
Natural bioactive gel to treat peri-implantitis around dental implants.
This study will try adding a natural bioactive gel (Sterify Gel®) to standard non-surgical cleaning to see if adults with peri-implantitis have less inflammation and bone loss around their implants.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.